Liveringhouse CL, Latifi K, Asous AG, Lam NB, et al. Dose Limiting Pulmonary Toxicity in a Phase I/II Study of Radiation and Chemotherapy with Ipilimumab followed by Nivolumab for Patients with Stage III Unresectable Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2023 Jan 16:S0360-3016(23)00046.
PMID: 36657497